Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 28 citing articles:

Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer
Hyein Jeong, Jaemoon Koh, Sehui Kim, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010612-e010612
Open Access | Times Cited: 2
Unraveling the causal role of immune cells in gastrointestinal tract cancers: insights from a Mendelian randomization study
Yuxiang Wang, Chao-ping Zhou, Da-tian Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Impact of immune checkpoint inhibitors and local radical treatment on survival outcomes in synchronous oligometastatic NSCLC
Mandy Jongbloed, Valentina Bartolomeo, Martina Bortolot, et al.
JTO Clinical and Research Reports (2025) Vol. 6, Iss. 3, pp. 100790-100790
Open Access | Times Cited: 1
Advances in nanotechnology for targeting cancer-associated fibroblasts: A review of multi-strategy drug delivery and preclinical insights
Zhongsong Zhang, Yujie Tang, Dan Luo, et al.
APL Bioengineering (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Advances in targeting tumor microenvironment for immunotherapy
Lugang Wang, Liubo Zhang, Zhen Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer
Jie Yao, Xuwen Lin, Xin Zhang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 4
Integrative multi-omics analysis for identifying novel therapeutic targets and predicting immunotherapy efficacy in lung adenocarcinoma
Zi‐Lu Chen, Kun Mei, Fraser Elisabeth Tan, et al.
Cancer Drug Resistance (2025)
Open Access
Concomitant exposure to benzodiazepines during pembrolizumab-based therapy for advanced non-small-cell lung cancer: a propensity-score matched analysis of monitoring agency data
Alejandra Vargas, Enzo Maria Ruggeri, Antonella Virtuoso, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Application of autologous platelet rich plasma in Sun's procedure for acute type A aortic dissection under moderate hypothermia
Kaiyue Sun, Ruyuan Wei, Zihua Liu, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
SGLT2i delays c-Myc-induced HCC progression via targeting mTOR
Huiling Rao, Xiaotong An, Xiaoyan Qu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167805-167805
Closed Access
Silencing of RNFT2 suppresses cell proliferation and migration through mTORC1 signaling pathway in gastric cancer
Younan Wang, Qianyun Ma, Zeyu Zhu, et al.
Amino Acids (2025) Vol. 57, Iss. 1
Open Access
Obstructive Sleep Apnea is an Independent Risk Factor for Pulmonary Nodules
Jianxiong Lai, Shenyu Wen, Jiahe Wang, et al.
Research Square (Research Square) (2025)
Closed Access
Shenfu injection alleviates lipopolysaccharide-induced liver injury in septic mice
Baozhong Lu, Yajun Wang, Lei Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Common biomarker genes associated with cardiovascular disease and diabetes mellitus: Implications for cross-disease therapeutic strategies and Cancer prognosis
Mahir Azmal, Jibon Kumar Paul, Tausif Alam, et al.
Human Gene (2025), pp. 201418-201418
Closed Access
Decoding resistance to immune checkpoint inhibitors in non-small cell lung cancer: a comprehensive analysis of plasma proteomics and therapeutic implications
Michal Harel, Nili Dahan, Coren Lahav, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 5, pp. e011427-e011427
Open Access
Addressing Clinical Limitations of Glutaminase Inhibitors: Novel Strategies for Osimertinib‐Resistant Lung Cancer by Exploiting Glutamine Metabolic Dependency
Jiali Huang, Xiankang Zhang, Hui Zhang, et al.
Advanced Science (2024)
Open Access | Times Cited: 3
Identification of C-PLAN index as a novel prognostic predictor for advanced lung cancer patients receiving immune checkpoint inhibitors
Jiaxin Wang, Huaijuan Guo, Jingjing Yang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy
Cedric Richlitzki, Marcel Wiesweg, Martin Metzenmacher, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Peripheral blood cytokines and outcomes with immune checkpoint blockade: a systematic review and meta-analysis
Alexander B. Karol, Yu Fujiwara, Tyler D’Ovidio, et al.
Immunotherapy (2024) Vol. 16, Iss. 12, pp. 829-840
Closed Access | Times Cited: 1
Effect of baseline anemia on the efficacy of docetaxel and ramucirumab for advanced non-small cell lung cancer treatment
Yoshitaka Saito, Yoh Takekuma, Jun Sakakibara‐Konishi, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Immunotherapy: remember the host
Paul R. Walker
Translational Lung Cancer Research (2023) Vol. 12, Iss. 12, pp. 2366-2369
Open Access | Times Cited: 1
Cachexia and Sarcopenia in Oligometastatic Non-Small Cell Lung Cancer: Making a Potential Curable Disease Incurable?
Valentina Bartolomeo, Mandy Jongbloed, Wouter R. P. H. van de Worp, et al.
Cancers (2024) Vol. 16, Iss. 1, pp. 230-230
Open Access
Peripheral Blood Biomarkers Predicting the Efficacy of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer: A Retrospective Study
Jinshan Yan, Xin Li, Hong Xiao, et al.
Research Square (Research Square) (2024)
Closed Access
β-glucan combined with Envafolimab and Endostar as immune rechallenge for metastatic non-small cell lung cancer
Qian Geng, Yingying Lu, Dongqing Li, et al.
BMC Immunology (2024) Vol. 25, Iss. 1
Open Access
Targeting CD73 for anti-tumor immunity
Shi Liu, Pierre-Antoine Laurent, Éric Deutsch, et al.
Elsevier eBooks (2024)
Closed Access
Page 1 - Next Page

Scroll to top